HSV -2, page-6

I think "Im QE" is very confused and did you read the whole thing or just want to manipulate.... the link you provided have this. So there are phases and just completed phase 1 successfully. At the end of all phases the vaccine will get 100% pass:

Over time the trials will be extended to test whether the vaccine also works to prevent the spread of the virus but this type of study takes a long period and must involve lots of people.

The Phase 1 trial produced a T-cell response in 95 per cent of the humans it was tested in.
T cells are killer cells that detect cells infected with a virus and kill them.

The study found variable evidence that the vaccine produced and antibody response to herpes simplex.
Mr Rhodes said the Phase 1 trial had given an indication of what strengths of the vaccine worked best and should be further tested.

If further testing was successful he said the treatment vaccine could be on the market within five years.